• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Global Substance Abuse Treatment Market to Grow at a CAGR of 5.15% By 2021 - Key Vendors are Alkermes, Allergan, GSK & Pfizer - Research and Markets

    Global Substance Abuse Treatment Market to Grow at a CAGR of 5.15% By 2021 - Key Vendors are Alkermes, Allergan, GSK & Pfizer - Research and Markets

  2. UPDATE: Five reasons you have to buy biotech stocks now

    UPDATE: Five reasons you have to buy biotech stocks now

  3. UPDATE: Three must-own cancer stocks for your biotechnology portfolio

    UPDATE: Three must-own cancer stocks for your biotechnology portfolio

  4. Global Substance Abuse Treatment Market - Size, Projections, Drivers, Trends, Vendors, and Analysis Through 2021 by Technavio

    Global Substance Abuse Treatment Market - Size, Projections, Drivers, Trends, Vendors, and Analysis Through 2021 by Technavio

  5. UPDATE: Five reasons you have to buy biotech stocks now

    UPDATE: Five reasons you have to buy biotech stocks now

  6. Global ENT Disorder Treatment Market 2017-2021 - Key Players are ALK, GSK , Novartis & Sanofi - Research and Markets

    Global ENT Disorder Treatment Market 2017-2021 - Key Players are ALK, GSK , Novartis & Sanofi - Research and Markets

  7. Global Lupus Nephritis Market: Industry Analysis & Outlook 2021-2030 with Profiles of the Leading 5 Companies - Aurinia Pharmaceuticals, Roche, Bristol-Myers Squibb, GSK & AstraZeneca - Research and ...

    Global Lupus Nephritis Market: Industry Analysis & Outlook 2021-2030 with Profiles of the Leading 5 Companies - Aurinia Pharmaceuticals, Roche, Bristol-Myers Squibb, GSK & AstraZeneca - Research and Markets

  8. Qatar Healthcare Market to 2021 - High Prevalence of Diabetes and Rising Healthcare Infrastructure to Foster Future Growth - Research and Markets

    Qatar Healthcare Market to 2021 - High Prevalence of Diabetes and Rising Healthcare Infrastructure to Foster Future Growth - Research and Markets

  9. Technavio Announces Key Highlights From Their Needle Free Drug Delivery, Antiemetic Drugs, and Scleroderma Treatment Reports

    Technavio Announces Key Highlights From Their Needle Free Drug Delivery, Antiemetic Drugs, and Scleroderma Treatment Reports

  10. GlaxoSmithKline Reports Positive Results For Malaria Treatment

    GlaxoSmithKline Reports Positive Results For Malaria Treatment

12345

©2017 Morningstar Advisor. All right reserved.